Alterations of the Wnt signaling pathway during the neoplastic progression of Barrett's esophagus

Oncogene

Volumn 25, Issue 21, 2006, Pages 3084-3092

  Clement G ^a   Braunschweig, R ^a   Pasquier, N ^a   Bosman, F T ^a   Benhattar, J ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

APC; Barrett's esophagus; DNA methylation; SFRP; Wnt pathway

Indexed keywords

BETA CATENIN; FRIZZLED PROTEIN; WNT PROTEIN; WNT2 PROTEIN;

ARTICLE; BARRETT ESOPHAGUS; CARCINOGENESIS; COLON POLYPOSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; DYSPLASIA; ESOPHAGUS CARCINOMA; ESOPHAGUS MUCOSA; GENE INACTIVATION; GENE TRANSLOCATION; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN METHYLATION;

ADENOCARCINOMA; AZACITIDINE; BARRETT ESOPHAGUS; BETA CATENIN; CELL DIVISION; CELL LINE, TUMOR; CPG ISLANDS; DISEASE PROGRESSION; DNA METHYLATION; DNA, NEOPLASM; ESOPHAGEAL NEOPLASMS; GENE EXPRESSION REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; GENES, APC; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MEMBRANE PROTEINS; MUCOUS MEMBRANE; NEOPLASM PROTEINS; PRECANCEROUS CONDITIONS; PROMOTER REGIONS (GENETICS); RNA, MESSENGER; RNA, NEOPLASM; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TRANSFECTION; WNT PROTEINS; WNT2 PROTEIN;

EID: 33646855775     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209338     Document Type: Article

References (51)

1. Baisse B, Bian YS, Benhattar J. (2000). Biotechniques 28: 856-858, 860, 862.
2. Benhattar J, Clement G. (2004). Methods Mol Biol 287: 181-193.
3. Bian YS, Osterheld MC, Bosman FT, Fontolliet C, Benhattar J. (2000). Am J Clin Pathol 114: 583-590.
4. Bian YS, Yan P, Osterheld MC, Fontolliet C, Benhattar J. (2001). Biotechniques 30: 66-72.
5. Bienz M, Clevers H. (2000). Cell 103: 311-320.
6. Blasband A, Schryver B, Papkoff J. (1992). Oncogene 7: 153-161.
7. Blot WJ, McLaughlin JK. (1999). Semin Oncol 26: 2-8.
8. Brabender J, Marjoram P, Salonga D, Metzger R, Schneider PM, Park JM et al. (2004). Oncogene 23: 4780-4788.
9. Bui TD, Zhang L, Rees MC, Bicknell R, Harris AL. (1997). Br J Cancer 75: 1131-1136.
10. Caldwell GM, Jones C, Gensberg K, Jan S, Hardy RG, Byrd P et al. (2004). Cancer Res 64: 883-888.
11. Clement G, Benhattar J. (2005). J Clin Pathol 58: 155-158.
12. Clement G, Bosman FT, Fontolliet C, Benhattar J. (2004). Cancer Res 64: 6867-6873.
13. Falk GW. (2002). Gastroenterology 122: 1569-1591.
14. Flejou JF. (2005). Gut 54: i6-i12.
15. Gonzalez MV, Artimez ML, Rodrigo L, Lopez-Larrea C, Menendez MJ, Alvarez V et al. (1997). J Clin Pathol 50: 212-217.
16. Guillou L, Coindre J, Gallagher G, Terrier P, Gebhard S, de Saint Aubain SN et al. (2001). Hum Pathol 32: 105-112.
17. He B, Lee AY, Dadfarmay S, You L, Xu Z, Reguart N et al. (2005). Cancer Res 65: 743-748.
18. Holcombe RF, Marsh JL, Waterman ML, Lin F, Milovanovic T, Truong T. (2002). Mol Pathol 55: 220-226.
19. Horii A, Nakatsuru S, Ichii S, Nagase H, Nakamura Y. (1993). Hum Mol Genet 2: 283-287.
20. Howng SL, Wu CH, Cheng TS, Sy WD, Lin PC, Wang C et al. (2002). Cancer Lett 183: 95-101.
21. Jenkins GJ, Doak SH, Parry JM, D'Souza FR, Griffiths AP, Baxter JN. (2002). Br J Surg 89: 824-837.
22. Katoh M. (2001a). Int J Mol Med 8: 657-660.
23. Katoh M. (2001b). Int J Oncol 19: 1003-1007.
24. Katoh M. (2003). Int J Mol Med 12: 811-816.
25. Kawano Y, Kypta R. (2003). J Cell Sci 116: 2627-2634.
26. Kitadai Y, Haruma K, Tokutomi T, Tanaka S, Sumii K, Carvalho M et al. (1998). Clin Cancer Res 4: 2195-2200.
27. Kobayashi K, Ouchida M, Tsuji T, Hanafusa H, Miyazaki M, Namba M et al. (2002). Gene 282: 151-158.
28. Koppert LB, van der Velden AW, van de Wetering M, Abbou M, van den Ouweland AM, Tilanus HW et al. (2004). Br J Cancer 90: 892-899.
29. Le Floch N, Rivat C, De WO, Bruyneel E, Mareel M, Dale T et al. (2005). FASEB J 19: 144-146.
30. Lee AY, He B, You L, Dadfarmay S, Xu Z, Mazieres J et al. (2004). Oncogene 23: 6672-6676.
31. Logan CY, Nusse R. (2004). Annu Rev Cell Dev Biol 20: 781-810.
32. McManus DT, Olaru A, Meltzer SJ. (2004). Cancer Res 64: 1561-1569.
33. Metzger R, Schneider PM, Warnecke-Eberz U, Brabender J, Holscher AH. (2004). Onkologie 27: 200-206.
34. Morin PJ. (1999). Bioessays 21: 1021-1030.
35. Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B et al. (1997). Science 275: 1787-1790.
36. Nishihira T, Hashimoto Y, Katayama M, Mori S, Kuroki T. (1993). J Cancer Res Clin Oncol 119: 441-449.
37. Nusse R, Varmus HE. (1982). Cell 31: 99-109.
38. Osterheld MC, Bian YS, Bosman FT, Benhattar J, Fontolliet C. (2002). Am J Clin Pathol 117: 451-456.
39. Pham K, Milovanovic T, Barr RJ, Truong T, Holcombe RF. (2003). Mol Pathol 56: 280-285.
40. Polakis P. (1999). Curr Opin Genet Dev 9: 15-21.
41. Polakis P. (2000). Genes Dev 14: 1837-1851.
42. Rhee CS, Sen M, Lu D, Wu C, Leoni L, Rubin J et al. (2002). Oncogene 21: 6598-6605.
43. Ricken A, Lochhead P, Kontogiannea M, Farookhi R. (2002). Endocrinology 143: 2741-2749.
44. Rockett JC, Larkin K, Darnton SJ, Morris AG, Matthews HR. (1997). Br J Cancer 75: 258-263.
45. Saitoh T, Mine T, Katoh M. (2002). Int J Mol Med 9: 515-519.
46. Seery JP, Syrigos KN, Karayiannakis AJ, Valizadeh A, Pignatelli M. (1999). Acta Oncol 38: 945-948.
47. Shih IM, Yu J, He TC, Vogelstein B, Kinzler KW. (2000). Cancer Res 60: 1671-1676.
48. Suzuki H, Watkins DN, Jair KW, Schuebel KE, Markowitz SD, Chen WD et al. (2004). Nat Genet 36: 417-422.
49. Tsuchiya T, Tamura G, Sato K, Endoh Y, Sakata K, Jin Z et al. (2000). Oncogene 19: 3642-3646.
50. Verma UN, Surabhi RM, Schmaltieg A, Becerra C, Gaynor RB. (2003). Clin Cancer Res 9: 1291-1300.
51. Worm J, Christensen C, Gronbaek K, Tulchinsky E, Guldberg P. (2004). Oncogene 23: 5215-5226.